Literature DB >> 8284379

Diabetic nephropathy: evaluation with renal duplex Doppler US.

J F Platt1, J M Rubin, J H Ellis.   

Abstract

PURPOSE: To compare Doppler ultrasonography (US) with conventional clinical and laboratory tests in evaluation of diabetic renal disease.
METHODS: Ninety-eight patients with diabetes mellitus underwent renal Doppler (resistive index [RI] measurement) US examination. US data were compared with clinical variables and follow-up data.
RESULTS: Thirty-four diabetic patients without nephropathy had a mean RI of 0.62 +/- 0.09, which was not significantly different from the mean RI of 0.64 +/- 0.09 in 23 patients with early diabetic nephropathy. Patients with established nephropathy had a mean RI of 0.83 +/- 0.11, which was significantly (P < .001) higher than in the other two groups. Renal RI correlated highly with serum creatinine concentration (r = .64) and creatinine clearance rate (r = .80). An elevated RI (> or = 0.70) was associated with impaired renal function, increased proteinuria at 24 hours, and poor outcome. Absent diastole (RI = 1.0), observed in 7% of patients, was an ominous sign: Five of seven patients underwent dialysis or transplantation shortly after US.
CONCLUSION: RI is typically elevated in established nephropathy but is often normal in the early clinical stages of disease. Renal Doppler US provides an accurate indication of renal function in diabetic nephropathy but does not offer a great advantage over conventional tests.

Entities:  

Mesh:

Year:  1994        PMID: 8284379     DOI: 10.1148/radiology.190.2.8284379

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

1.  Diffusion-weighted MR imaging and Doppler ultrasonography in the evaluation of renal parenchyma in acute ureteral obstruction.

Authors:  Fatma Nur Soylu Boy; Arda Kayhan; Hakki Muammer Karakas; Turgut Alp; Ayhan Verit
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood.

Authors:  Cosimo Giannini; Ebe D'Adamo; Tommaso de Giorgis; Valentina Chiavaroli; Alberto Verrotti; Francesco Chiarelli; Angelika Mohn
Journal:  Pediatr Nephrol       Date:  2011-08-26       Impact factor: 3.714

Review 3.  Diagnostic and prognostic utility of non-invasive imaging in diabetes management.

Authors:  Cristina Barsanti; Francesca Lenzarini; Claudia Kusmic
Journal:  World J Diabetes       Date:  2015-06-25

4.  Value of Doppler ultrasonography in predicting deteriorating renal function after spinal cord injury.

Authors:  Fan-Fei Tseng; Yu-Hui Huang; Sung-Lang Chen; Su-Ju Tsai; Chi-Chung Ho; Liu-Ing Bih
Journal:  Radiol Med       Date:  2011-10-21       Impact factor: 3.469

Review 5.  Application of ultrasonography and the resistive index for evaluating bladder outlet obstruction in patients with benign prostatic hyperplasia.

Authors:  Hitoshi Shinbo; Yutaka Kurita
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

6.  The role of ultrasonography in the study of medical nephropathy.

Authors:  F Fiorini; L Barozzi
Journal:  J Ultrasound       Date:  2007-11-05

7.  Usefulness of Doppler ultrasound for the early diagnosis of diabetic nephropathy in type 1 diabetes mellitus.

Authors:  Azar Nickavar; Baranak Safaeian; Hossein Zaeri; Mohammad Hadi Gharib; Tahereh Chaharnaei
Journal:  J Ultrasound       Date:  2021-02-20

8.  Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.

Authors:  Haiyang Li; Yunzhu Shen; Zhikai Yu; Yinghui Huang; Ting He; Tangli Xiao; Yan Li; Jiachuan Xiong; Jinghong Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-14       Impact factor: 5.555

9.  Association between intrarenal arterial resistance and diastolic dysfunction in type 2 diabetes.

Authors:  Richard J MacIsaac; Merlin C Thomas; Sianna Panagiotopoulos; Trudy J Smith; Huming Hao; D Geoffrey Matthews; George Jerums; Louise M Burrell; Piyush M Srivastava
Journal:  Cardiovasc Diabetol       Date:  2008-05-23       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.